Skip to content

Author

K. Schubert

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Prognosis of acute symptomatic seizures and impact of prolonged treatment with anti-seizure medication.

OBJECTIVES Acute symptomatic epileptic seizures (ASySs) occur in temporal proximity to acute brain insults. Given their low risk of subsequent unprovoked seizures, current guidelines recommend either no treatment with anti-seizure medication (ASM) or early discontinuation, yet ASM treatment is often continued beyond ho...

Hannah Traben, Julia Herzig-Nichtweiß, L. Langenbruch et al. · 0 citations
Open access Aug 2026

Safety of Antiseizure Medications During Direct Oral Anticoagulant Therapy in Epilepsy.

Importance Concomitant use of antiseizure medications (ASMs) and direct oral anticoagulants (DOACs) is common in epilepsy, but comparative safety data remain limited. Objective To compare risks of thromboembolic events, major bleeding, and all-cause mortality across commonly used ASMs in adults with epilepsy receivin...

K. Schubert, C. Ferreira-Atuesta, Arunachalam Soma et al. · 0 citations
Open access Sep 2026

Proteomic-guided targeted treatment of leukoencephalopathy with calcification and cysts.

Precision therapeutic approaches for rare neurological diseases are often hampered by a limited molecular understanding of the disease. Here, we report the first application of spatially-resolved proteomics to guide targeted treatment in a monogenic leukoencephalopathy. We investigated leukoencephalopathy with calcific...

Nils Briel, A. Köpp, Hanna Meister et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.